Skip to main content
SpringerLink
Log in

Markers of prognosis in breast cancer - the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Abnormal cellular glycosylation as demonstrated by the binding of a lectin fromHelix pomatia (HPA) to paraffin-embedded sections has been shown in several studies to be associated with aggressive biological behaviour and poor long-term patient prognosis in breast cancer. This study aims to address the possibility that expression of the HPA binding ligand may be of prognostic significance through an association with increased cellular proliferation (as measured by S-phase fraction and histological grade), anaplasia (reflected in histological grade), or ploidy (DNA index).

In a 24 year retrospective study, paraffin-embedded sections of 366 primary breast cancers were stained for binding of HPA. All tumours were assessed for histological grade. Flow cytometry was performed on all cases for which sufficient tumour tissue was available (358/366 cases) and S-phase fraction (SPF) and ploidy calculated. Data regarding patient age at diagnosis, nodal status, and tumour size were also recorded.

Life table analyses revealed survival advantage for HPA ‘non stainers’ in comparison to ‘stainers’ (p< 0.001); for patients with tumours of low grade vs. high grade (p<0.001); and for those with tumours of low SPF vs. high SPF (p<0.001). No survival advantage was shown for those with diploid vs. aneuploid tumours (p= 0.17). No association was apparent between HPA binding and grade, SPF, or ploidy (Chi squared values not significant). This was confirmed by multivariate analysis in which nodal status, tumour size, and SPF were independently predictive of survival. There was no confounding effect of grade, SPF, or ploidy upon the correlation between survival and HPA binding. HPA was, however, not independently predictive owing to its strong association with nodal status.

The results of this study suggest that the prognostic significance of altered glycosylation, as detected by HPA binding, is unlikely to be through an association with proliferative rate, degree of anaplasia, or cellular ploidy, but may rather be through a direct association with the presence of nodal metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bloom HGJ, Richardson WW: Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 360–377, 1957

    Google Scholar 

  2. Scarff R, Torlini H: International histological classification of tumours. Number 2: Histological typing of breast tumours. WHO, Geneva, 1968

    Google Scholar 

  3. Freedman LS, Edwards DN, McConnell EM, Downham DY: Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer 40: 44–55, 1979

    Google Scholar 

  4. Elston CW, Gresham GA, Rao GS, Zebro T, Haybittle JL, Houghton J, Kearney G: The Cancer Research Campaign (Kings/Cambridge) trial for early breast cancer: Clinicopathological aspects. Br J Cancer 45: 655–669, 1982

    Google Scholar 

  5. Delides GS, Garas G, Georgouli G, Jiortziotis D, Lecca J, Liva T, Elemenoglou J: Interlaboratory variations in the grading of breast cancer. Arch Pathol Lab Med 106: 126–128, 1982

    Google Scholar 

  6. Sunderland MC, McGuire WL: Prognostic indicators in invasive breast cancer. Surg Clin North Am 70: 989–1004, 1990

    Google Scholar 

  7. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333–1335, 1983

    Google Scholar 

  8. Kallioniemi O-P, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T: Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol 23: 277–282, 1987

    Google Scholar 

  9. Yokoe T, Izuo M, Ishida T, Iino Y, Kawai T: DNA ploidy level and S-phase fraction as prognostic factors in breast cancer. Jpn J Surg 20: 491–497, 1990

    Google Scholar 

  10. O'Reilly SM, Camplejohn RS, Barnes DM, Millis RR, Allen D, Rubens RD, Richards MA: DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer 61: 671–674, 1990

    Google Scholar 

  11. Feichter GE, Mueller A, Kaufmann M, Haag D, Born IA, Abel U, Klinga K, Kubli F, Goerttler K: Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer. Int J Cancer 41: 823–828, 1988

    Google Scholar 

  12. Aasmundstad TA, Haugen OA: DNA ploidy in intraductal breast carcinomas. Eur J Cancer 26: 956–959, 1990

    Google Scholar 

  13. Atkin NB: Modal deoxyribonucleic acid value and survival in carcinoma of the breast. BMJ 1: 271–272, 1972

    Google Scholar 

  14. Atkin NB, Kay R: Prognostic significance of modal DNA value and other factors in malignant tumours based on 1456 cases. Br J Cancer 40: 210–221, 1979

    Google Scholar 

  15. Auer GU, Eriksson E, Azavedo E, Casperson TD, Wallgren AS: Prognostic significance of nuclear DNA content in mammary adenocarcinoma in humans. Cancer Res 44: 394–396, 1984

    Google Scholar 

  16. Beerman H, Kluin PM, Hermans J, van-de-Velde CJ, Cornelisse CJ: Prognostic significance of DNA ploidy in a series of 690 primary breast cancer patients. Int J Cancer 45: 34–39, 1990

    Google Scholar 

  17. Seymour L, Bezwoda WR, Meyer K: Tumor factors predicting for prognosis in metastatic breast cancer. The presence of p24 predicts for response to treatment and duration of survival. Cancer 66: 2390–2394, 1990

    Google Scholar 

  18. Dowle CS, Owainati A, Robins A, Burns K, Ellis IO, Elston CW, Blamey RW: Prognostic significance of the DNA content of human breast cancer. Br J Surg 74: 133–136, 1987

    Google Scholar 

  19. Owainati AAR, Robins RA, Hinton C, Ellis IO, Dowle CS, Ferry B, Elston CW, Blamey RW, Baldwin RW: Tumour aneuploidy, prognostic parameters and survival in primary breast cancer. Br J Cancer 55: 449–454, 1987

    Google Scholar 

  20. Brooks SA, Leathem AJC: Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour. The Lancet 338: 71–74, 1991

    Google Scholar 

  21. Fenlon S, Ellis IO, Bell J, Todd JH, Elston CW, Blamey RW:Helix pomatia andUlex europeus lectin binding in human breast carcinoma. J Pathol 152: 169–176, 1987

    Google Scholar 

  22. Fukutomi T, Itabashi M, Tsugane S, Yamamoto H, Nanasawa T, Hirota T: Prognostic contributions ofHelix pomatia lectin and carcinoembryonic antigen staining using histochemical techniques in breast carcinomas. Jpn J Clin Oncol 19: 127–134, 1989

    Google Scholar 

  23. Alam SM, Whitford P, Cushley W, George WD, Campbell AM: Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer. Br J Cancer 62: 238–242, 1990

    Google Scholar 

  24. Kakeji Y, Tsujitani S, Mori M, Maehara Y, Sugimachi K:Helix pomatia agglutinin binding activity is a predictor of survival time for patients with gastric carcinoma. Cancer 68: 2438–2442, 1991

    Google Scholar 

  25. Galea MH, Ellis IO, Bell J, Elston CW, Blamey RW: Prediction of lymph node involvement in breast cancer (letter). The Lancet 338: 392–393, 1991

    Google Scholar 

  26. Taylor CW, Anbazhagan R, Jayatilake H, Adams A, Gusterson BA, Price K, Gelber RD, Goldhirsch A:Helix pomatia and breast cancer (letter). The Lancet 338: 580, 1991

    Google Scholar 

  27. Hammarstrom S, Kabat EA: Purification and characterisation of a blood group A reactive hemagglutinin from the snailHelix pomatia and a study of its combining site. Biochemistry 8: 2696–2705, 1969

    Google Scholar 

  28. Baker DA, Sugii S, Kabat EA, Ratcliffe RM, Hermentin P, Limieux RU: Immunochemical studies on the combining sites of Forssman hapten reactive hemagglutinins fromDolichos biflorus, Helix pomatia, andWisteria floribunda. Biochemistry 22: 2741–2750, 1983

    Google Scholar 

  29. Leathem AJ, Brooks SA: Predictive value of lectin binding on breast cancer recurrence and survival. Lancet i: 1054–1056, 1987

    Google Scholar 

  30. Camplejohn RS, Macartney JC, Morris RW: Measurement of S-phase fractions in lymphoid tissue comparing fresh versus paraffin-embedded tissue and 4′6′-diamidino-2 phenylindole dihydrochloride versus propidium iodide staining. Cytometry 10: 410–416, 1989

    Google Scholar 

  31. Hedley DW, Rugg CA, Gelber RD: Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res 47: 4729–4735, 1987

    Google Scholar 

  32. Baisch H, Gohde W, Linden WA: Analysis of PCP-data to determine the fraction of cells in various phases of the cell cycle. Radiat Environmen Biophys 12: 31–39, 1975

    Google Scholar 

  33. Kaplan EL, Meier P: A non-parametric estimate from incomplete observations. Am Stat Assoc J 53: 457–481, 1958

    Google Scholar 

  34. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith JG: Design and analysis of clinical trials requiring prolonged observation of each patient. II, analysis and examples. Br J Cancer 35: 1–39, 1977

    Google Scholar 

  35. Cox DR: Regression models and life tables. J Royal Stat Soc (B) 34: 187–220, 1972

    Google Scholar 

  36. Springer GF: Tn epitope (N-acetyl-D-galactosamine alpha-O-serine/threonine) density in primary breast carcinoma. A functional predictor of agressiveness. Mol Immunol 26: 1–5, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University College London Medical School, The Rayne Institute, 5 University Street, WC1E 6JJ, London, UK

    Susan A. Brooks & Anthony J. C. Leathem

  2. Richard Dimbleby Department of Cancer Research, United Medical and Dental Schools, St. Thomas' Hospital, SE1 7EH, London, U.K.

    Richard S. Camplejohn

  3. ICRF Department of Clinical Oncology, Guy's Hospital, SE1 9RT, London, U.K.

    Walter Gregory

Authors
  1. Susan A. Brooks
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony J. C. Leathem
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard S. Camplejohn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Walter Gregory
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brooks, S.A., Leathem, A.J.C., Camplejohn, R.S. et al. Markers of prognosis in breast cancer - the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy. Breast Cancer Res Tr 25, 247–256 (1993). https://doi.org/10.1007/BF00689839

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00689839

Key words

Search

Navigation